Date
Title
Mar 02, 2022

Innocoll Announces Positive Topline Results for Xaracoll® (Bupivacaine Hydrochloride) Implant in a Phase 3 Study to Support Expanded Use

Feb 25, 2022

Innocoll Announces Co-Promotion Agreement for Hernia Product Portfolio

Feb 22, 2022

Innocoll Announces Successful Completion of Debt Refinancing

Business Development Group
Unit 9, Block D
Monksland Business Park
Monksland
Athlone
Co. Roscommon
Ireland

Phone: +353 (0)90 648 6834
Fax: +353 (0)90 648 6835
E-mail: inquiries@innocoll.com

Innocoll Holdings Limited, a private company limited by shares, incorporated in Ireland having company number 544604 and its registered office at 70 Sir John Rogerson’s Quay, Dublin 2, Ireland.

© 2020-2004 Innocoll. All rights reserved.
All Trademarks are owned by Innocoll Pharmaceuticals Limited